Initially — and most controversially — SB25-076 also looked to cap the potency level and amount of cannabis someone 25 or ...

Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in ...

TORONTO, ON / ACCESS Newswire / March 5, 2025 / NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE:AIAI)(OTCQB:AINMF)(Frankfurt:8TV) a generative AI software leader in clinical trial analytic ...

The company’s product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for ...

Studies suggest that TRS occurs in about 22 percent of people who have a first episode of psychosis (meaning the first time schizophrenia symptoms appear) and in 39.5 percent of those who have had ...

PET has therefore been used to gain insight into neurochemical pathways (1,2). Patients with schizophrenia show heightened dopaminergic transmission leading to synaptic dysregulation (3,4), which is ...

Brexpiprazole's indication for the treatment of schizophrenia in adults is extended to include adolescents aged 13 years and older1Approval follows a positive Committee for Medicinal Products ...

These daydreams are not hallucinations or delusions that completely detach from reality—as daydreams can be with schizophrenia. There aren't yet any clear known causes of SPD. However, there are life ...

He was responding to another tweet—a screenshot of the Om symbol done up in lilac camo ... do with AI and the blockchain involving mystic schizo-poetry, videos like visions of Robo-trips ...

Clozapine, which was approved in 1989, is regarded by many physicians as the most effective available treatment for schizophrenia, and research shows that the drug significantly reduces suicidal ...

The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the brain. The symptoms of schizophrenia vary ...

Sex-specific association between schizophrenia polygenic risk and subclinical schizophrenia-related traits. Progress in Neuro-Psychopharmacology and Biological Psychiatry , 2025; 136: 111161 DOI ...